EGFR and lung adenocarcinoma: In the current study, 570 patients with lung adenocarcinoma referred to the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) were investigated for EGFR mutation to identify the frequency of this mutation among Iranian lung cancer patients.